Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease, Idiopathic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00437125
What this trial is testing

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Who this might be right for
Major Depressive DisorderIdiopathic Parkinson Disease
Eli Lilly and Company 151
Not applicableStudy completedNCT02263885
What this trial is testing

ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
InSightec 20
Post-approval studies (Phase 4)Ended earlyNCT01519882
What this trial is testing

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease

Who this might be right for
Advanced Idiopathic Parkinson's Disease
UCB Pharma SA 1
Early research (Phase 1)Study completedNCT00252850
What this trial is testing

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
Sangamo Therapeutics 12
Not applicableStudy completedNCT03645226
What this trial is testing

Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 441
Large-scale testing (Phase 3)Study completedNCT01568073
What this trial is testing

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 600
Post-approval studies (Phase 4)Study completedNCT04510922
What this trial is testing

Lundbeck TOMs Orthostatic Hypotension

Who this might be right for
Orthostatic HypotensionIdiopathic Parkinson Disease
Alberto Espay, MD, MSc 9
Not applicableStudy completedNCT00465790
What this trial is testing

Research of Biomarkers in Parkinson Disease

Who this might be right for
Parkinson DiseaseMultiple System AtrophyProgressive Supranuclear Palsy+3 more
Institut National de la Santé Et de la Recherche Médicale, France 219
Not applicableStudy completedNCT01330290
What this trial is testing

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma 148
Testing effectiveness (Phase 2)Study completedNCT00866502
What this trial is testing

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Sweden AB 12
Not applicableStudy completedNCT06390163
What this trial is testing

Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson Disease
Hacettepe University 40
Large-scale testing (Phase 3)Ended earlyNCT00519532
What this trial is testing

Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 84
Post-approval studies (Phase 4)Study completedNCT00594464
What this trial is testing

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Who this might be right for
Parkinson's Disease
UCB Pharma 14
Large-scale testing (Phase 3)Study completedNCT01155466
What this trial is testing

A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)

Who this might be right for
Parkinson Disease
Merck Sharp & Dohme LLC 778
Large-scale testing (Phase 3)Study completedNCT03670953
What this trial is testing

Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Who this might be right for
Parkinson's Disease (Disorder)
Impax Laboratories, LLC 630
Large-scale testing (Phase 3)Study completedNCT02610231
What this trial is testing

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Kyowa Kirin Co., Ltd. 239
Not applicableStudy completedNCT02246374
What this trial is testing

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
InSightec 7
Not applicableStudy completedNCT02227355
What this trial is testing

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
UCB Biopharma S.P.R.L. 195
Not applicableStudy completedNCT01272687
What this trial is testing

Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
CENTOGENE GmbH Rostock 1,500
Post-approval studies (Phase 4)UnknownNCT01007630
What this trial is testing

A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients

Who this might be right for
Parkinson's Disease
The Parkinson's Institute 36
Next Page